These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 2531153)

  • 1. Comparison between the effects of nafarelin and danazol on serum lipids and lipoproteins in patients with endometriosis.
    Välimäki M; Nilsson CG; Roine R; Ylikorkala O
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1097-103. PubMed ID: 2531153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic changes during medical treatment of endometriosis: nafarelin acetate versus danazol.
    Burry KA; Patton PE; Illingworth DR
    Am J Obstet Gynecol; 1989 Jun; 160(6):1454-9; discussion 1459-61. PubMed ID: 2525337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of plasma lipids and lipoprotein levels during danazol treatment for endometriosis.
    Schweppe KW; Assmann G
    Horm Metab Res; 1984 Nov; 16(11):593-7. PubMed ID: 6510890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of danazol on serum lipid and lipoprotein levels in patients with endometriosis].
    Fukuda Y; Tamura S
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jun; 39(6):980-6. PubMed ID: 3611874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial.
    Henzl MR; Corson SL; Moghissi K; Buttram VC; Berqvist C; Jacobson J
    N Engl J Med; 1988 Feb; 318(8):485-9. PubMed ID: 2963213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal effects of danazol and medical oophorectomy in endometriosis.
    Meldrum DR; Pardridge WM; Karow WG; Rivier J; Vale W; Judd HL
    Obstet Gynecol; 1983 Oct; 62(4):480-5. PubMed ID: 6350956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profound alterations of the lipoprotein metabolism during danazol treatment in premenopausal women.
    Fåhraeus L; Larsson-Cohn U; Ljungberg S; Wallentin L
    Fertil Steril; 1984 Jul; 42(1):52-7. PubMed ID: 6724013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of nafarelin acetate and danazol in the treatment of endometriosis.
    Kennedy SH; Williams IA; Brodribb J; Barlow DH; Shaw RW
    Fertil Steril; 1990 Jun; 53(6):998-1003. PubMed ID: 2140996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nafarelin versus danazol in the treatment of endometriosis.
    Rolland R; van der Heijden PF
    Am J Obstet Gynecol; 1990 Feb; 162(2):586-8. PubMed ID: 2137976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiendometrial antibodies in endometriosis measured by an enzyme-linked immunosorbent assay before and after treatment with danazol and nafarelin.
    Kennedy SH; Starkey PM; Sargent IL; Hicks BR; Barlow DH
    Obstet Gynecol; 1990 Jun; 75(6):914-8. PubMed ID: 2140439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of nafarelin in the treatment of endometriosis.
    Henzl MR; Kwei L
    Am J Obstet Gynecol; 1990 Feb; 162(2):570-4. PubMed ID: 2137971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zoladex versus danazol in the treatment of pelvic endometriosis: effects on plasma lipid risk factors.
    Crook D; Gardner R; Worthington M; Nolan J; Stevenson JC; Shaw RW
    Horm Res; 1989; 32 Suppl 1():157-60. PubMed ID: 2533147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative treatment trial of endometriosis using the gonadotrophin-releasing hormone agonist, nafarelin, and the synthetic steroid, danazol.
    Fraser IS; Shearman RP; Jansen RP; Sutherland PD
    Aust N Z J Obstet Gynaecol; 1991 May; 31(2):158-63. PubMed ID: 1834049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the effects of Buserelin versus danazol on plasma lipoproteins during treatment of pelvic endometriosis.
    Dlugi AM; Rufo S; D'Amico JF; Seibel MM
    Fertil Steril; 1988 May; 49(5):913-6. PubMed ID: 3129319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical treatment of endometriosis: a comparison of the suppressive effects of danazol and nafarelin on reproductive hormones.
    Hickok LR; Burry KA; Cohen NL; Moore DE; Dahl KD; Soules MR
    Fertil Steril; 1991 Oct; 56(4):622-7. PubMed ID: 1833245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nafarelin versus danazol on lipids and calcium metabolism.
    Bergquist C
    Am J Obstet Gynecol; 1990 Feb; 162(2):589-91. PubMed ID: 2137977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol, high density lipoprotein and danazol.
    Allen JK; Fraser IS
    J Clin Endocrinol Metab; 1981 Jul; 53(1):149-52. PubMed ID: 7240372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of nafarelin and danazol on vertebral trabecular bone mass in patients with endometriosis.
    Whitehouse RW; Adams JE; Bancroft K; Vaughan-Williams CA; Elstein M
    Clin Endocrinol (Oxf); 1990 Sep; 33(3):365-73. PubMed ID: 2147597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the origin and significance of serum CA-125 concentrations in 97 patients with endometriosis before, during, and after buserelin acetate, nafarelin, or danazol.
    Franssen AM; van der Heijden PF; Thomas CM; Doesburg WH; Willemsen WN; Rolland R
    Fertil Steril; 1992 May; 57(5):974-9. PubMed ID: 1533376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with nafarelin for endometriosis in young women. Efficacy, safety and lipid metabolism. Niigata Nafarelin Study Group.
    Kurabayashi T; Takakuwa K; Tanaka K
    J Reprod Med; 2000 Jun; 45(6):454-60. PubMed ID: 10900577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.